Kivo Health Virtual Pulmonary Rehabilitation Program
AI-powered virtual pulmonary rehab and care program for COPD patients
Company profile
Company profile
Kivo Health is a digital therapeutics company that delivers AI-powered virtual pulmonary rehabilitation and care programs specifically designed for people managing chronic obstructive pulmonary disease (COPD). The company's mission is to empower one billion people with chronic lung disease to breathe easier and live better. Kivo's evidence-based program is delivered entirely from patients' homes, eliminating access barriers associated with traditional in-person pulmonary rehabilitation. The program includes a comprehensive 9-week structured intervention featuring one-on-one assessments with licensed respiratory therapists, personalized small group video sessions twice weekly, targeted aerobic and anaerobic exercises, breathing techniques, medication management education, and ongoing maintenance support. Patients receive a complete kit with tablet, oxygen monitor, and exercise equipment, with cellular connectivity provided for those without WiFi. The program demonstrates strong clinical outcomes with 24% improvement in symptoms, 34% improvement in physical activity, 25% improvement in mood, and an industry-leading 83% completion rate. For healthcare partners, Kivo delivers a 3.1x return on investment, primarily through reduced inpatient and skilled nursing facility costs, with projected savings of $8,245 per member per year and nearly $10 million in annual savings per 100,000 Medicare Advantage members. The company is backed by Y Combinator and serves individuals, physicians, health systems, population health organizations, and health plans including Medicare, Medicaid, United Healthcare, Humana, Blue Cross, Aetna, Priority Health, and Clover Health.
Company description Kivo Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
April 2026: Partnership with Optum Arcadia for AI-powered virtual lung rehab in California. December 2025: Partnership with Priority Health. July 2025: Collaboration with Stanford Health Care. June 2025: Stanford Health Care collaboration for value-based care. May 2025: Published positive results in peer-reviewed study. February 2023: Company launch backed by Y Combinator.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered virtual pulmonary rehab and care program for COPD patients
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
COPD patients completing 9-week program
COPD patients completing program
COPD patients completing program
Industry-leading adherence
Medicare Advantage plans
High-risk COPD members, primarily through reduced inpatient and SNF costs
Per 100,000 Medicare Advantage members
Patient satisfaction score
AI-powered virtual lung rehab and care for patients in California
Partnership to provide virtual pulmonary rehabilitation for COPD patients
Virtual COPD care and value-based care advancement through virtual pulmonary rehabilitation
Reducing utilization costs for high-risk COPD members through virtual pulmonary rehabilitation
3.1x ROI, $8,245 PMPY in predicted cost savings, $9.8M projected annual savings per 100,000 MA members
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Kivo Health's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.